CompletedNot Applicable

Efficacy of Endoscopic Band Ligation (DEBL) for Duodenal Neuroendocrine Neoplasms(dNENs)

India50 participantsStarted 2024-02-29

Plain-language summary

Primary objective To evaluate the therapeutic efficacy (clinical success) of dEBL at 3 months 2b. Secondary objective To evaluate adverse events, technical success and recurrence on follow-up 50 patients over 1-year duration based on our previous study of Prospective data (2023-2024)

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients age \>18 years * Size of lesion less than 15mm * Site of lesion- duodenum (d1-d4) * No of lesions- ≤6 Exclusion Criteria: * Age less than 18 years * Non-duodenal lesion * Local or distant metastasis * Lumen occluding lesions * Uncorrectable coagulopathy * Not willing for consent

What they're measuring

Therapeutic efficacy (clinical success) of dEBL at 3 months and 1 year

Timeframe: One year

Trial details

NCT IDNCT06790056

SponsorAsian Institute of Gastroenterology, India

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11-10

View on ClinicalTrials.gov More Duodenal Neuroendocrine Tumor trials